Vocal Delivery as a Novel Risk Indicator: Evidence from Corporate Earnings Calls
The Journal of Portfolio Management · 30.06.2026 · 52 (8) · 146-174
DOI: 10.3905/jpm.2026.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Portfolio Management, online erschienen am 13.05.2026. Verfasst von David Pope.
Abstract (Originalsprache)
Management routinely conveys previously material nonpublic information to the market during earnings calls, and these disclosures move stock prices. Although communication in this setting is inherently multimodal, market participants overwhelmingly focus on the words spoken, treating transcripts as sufficient representations of managerial intent and conviction. This article introduces vocal delivery as a novel measure of managerial uncertainty and communication risk in corporate earnings calls. Using acoustic features extracted from CEO and CFO speech during unscripted question-and-answer segments, the authors show that vocal characteristics measure information about internal state, cognitive load, and conviction that is not reflected in textual disclosures or traditional financial metrics. These vocal signals are associated with subsequent price adjustments consistent with an initial misestimation of firm-level uncertainty. The findings imply that corporate disclosure is inherently multimodal and that incorporating vocal delivery improves the measurement of risk at the time of disclosure.
Zitieren
APA
Pope, D. (2026). Vocal Delivery as a Novel Risk Indicator: Evidence from Corporate Earnings Calls. The Journal of Portfolio Management, 52(8), 146-174. https://doi.org/10.3905/jpm.2026.015
Vancouver
Pope D. Vocal Delivery as a Novel Risk Indicator: Evidence from Corporate Earnings Calls. The Journal of Portfolio Management. 2026;52(8):146-174. doi:10.3905/jpm.2026.015
BibTeX
@article{Pope2026,
author = {Pope, David},
title = {Vocal Delivery as a Novel Risk Indicator: Evidence from Corporate Earnings Calls},
journal = {The Journal of Portfolio Management},
year = {2026},
volume = {52},
number = {8},
pages = {146--174},
doi = {10.3905/jpm.2026.015}
}
EUVIMED